Nonpediatric Specialties Face Smaller Return Margins for HPV Vaccine Costs
MONDAY, July 31, 2023 (HealthDay News) — For nonpediatric specialties, return margins for human papillomavirus (HPV) vaccine costs by private payers are small, according to a study published in the July/August issue of the Annals of Family Medicine.Y…
Learn MoreUno de cada 6 niños no ha recibido todas sus vacunas. ¿A qué se debe?
MARTES, 25 de julio de 2023 (HealthDay News) — La mayoría de las vacunas de la niñez temprana requieren tres o cuatro dosis para la mejor protección, pero más de 1 de cada 6 niños pequeños no las recibe en lo absoluto, lo que los deja vulnerables a i…
Learn More17.2 Percent of Children Start but Do Not Complete Seven-Vaccine Series
TUESDAY, July 25, 2023 (HealthDay News) — Overall, 17.2 percent of children initiated, but did not complete, the combined seven-vaccine early childhood series, according to a study published online July 25 in Pediatrics.Sarah Y. Michels, M.P.H., from…
Learn More17.2 Percent of Children Start but Do Not Complete Seven-Vaccine Series
TUESDAY, July 25, 2023 (HealthDay News) — Overall, 17.2 percent of children initiated, but did not complete, the combined seven-vaccine early childhood series, according to a study published online July 25 in Pediatrics.Sarah Y. Michels, M.P.H., from…
Learn More1 in 6 Kids Haven’t Gotten All of Their Vaccines. Why?
TUESDAY, July 25, 2023 (HealthDay News) — Most early childhood vaccines require three or four doses for best protection, but more than 1 in 6 toddlers aren’t getting them all, leaving them vulnerable to potentially deadly infections, a new study find…
Learn MoreMaternal Vaccine Can Prevent Group B Strep in Young Infants
FRIDAY, July 21, 2023 (HealthDay News) — A hexavalent capsular polysaccharide (CPS)-cross-reactive material 197 glycoconjugate vaccine (GBS6) can prevent invasive group B streptococcus in young infants, according to a study published in the July 20 i…
Learn MoreMaternal Vaccine Can Prevent Group B Strep in Young Infants
FRIDAY, July 21, 2023 (HealthDay News) — A hexavalent capsular polysaccharide (CPS)-cross-reactive material 197 glycoconjugate vaccine (GBS6) can prevent invasive group B streptococcus in young infants, according to a study published in the July 20 i…
Learn MoreLa FDA aprueba un nuevo fármaco para proteger a los bebés del VSR
LUNES, 17 de julio de 2023 (HealthDay News) — Ahora, los padres cuentan con un nuevo medicamento de larga acción para proteger a sus hijos del virus sincitial respiratorio (VSR), un germen común que cada año envía a hasta un 3 por ciento de los niños…
Learn MoreFDA Approves New Drug to Protect Against RSV in Infants
MONDAY, July 17, 2023 (HealthDay Now) — Parents now have a new long-acting drug to protect their children against respiratory syncytial virus (RSV), a common germ that hospitalizes as many as 3% of children under the age of 1 in the United States eac…
Learn MoreLos CDC aprueban vacunas contra el VSR para personas de a partir de 60 años; estarán disponibles en otoño
JUEVES, 29 de junio de 2023 (HealthDay News) — Este otoño, los estadounidenses de a partir de 60 años podrán ponerse una vacuna contra el virus sincitial respiratorio (VSR), anunciaron el jueves los Centros para el Control y la Prevención de Enfermed…
Learn More